Institut Bordet - Retour à la page d'accueil
en
I want to donate to research

 News

The Bordet Institute's tumour bank opens its doors to patients associations

Press release (01/12/2022)  The Jules Bordet Institute's tumour bank opens its doors to patients associations Brussels, 1 December 2022 – This Thursday 1 December, patients associations are invited to visit the tumour biobank of the Jules Bordet Institute, a part of the Brussels University Hospital (H.U.B.). At the initiative of the BBRMI (Biobanking and biomolecular resources research infrastructure of Belgium) and of the LUSS (League of…
(read more)

Agents antimicrobiens : à manipuler avec précaution

Actualité publiée le 24/11/2022 AGENTS ANTIMICROBIENS : À MANIPULER AVEC PRÉCAUTION Semaine mondiale pour un bon usage des antimicrobiens (18-24 novembre 2022)
La résistance aux antimicrobiens (antibiotiques, mais aussi antifongiques, antiviraux et antiparasitaires) est aujourd’hui l’une des plus grandes menaces pour la santé mondiale, la sécurité alimentaire et le développement. Les antimicrobiens sont des substances utilisées pour…
(read more)

A brand new website for the H.U.B !

Press release (22/11/2022)  A BRAND NEW WEBSITE FOR THE H.U.B !
The Brussels University Hospital is proud to announce the launch of its website! A central information platform for patients, partners and staff. The H.U.B. or the coming together of three renowned institutions.
The Brussels University Hospital, created in October 2021, is the Academic Hospital of the ULB. It brings together the Erasmus Hospital, the Jules Bordet…
(read more)

"EARLY PANC": Pancreatic cancer screening

Press release 17/11/2022 "EARLY PANC": Pancreatic cancer, an essential screening for persons at risk 17 November 2022, world pancreatic cancer day, is the ideal occasion to get screened. The aim of a personalised screening is to inform and raise awareness among the general public of a cancer that remains poorly understood as the number of cases continues to rise. It is now the fourth most common cancer worldwide.    
This silent and…
(read more)

Movember 2022

Press release 09/11/2022 MOVEMBER – The latest on preventing and screening for male cancers The Brussels University Hospital, composed of the Erasmus Hospital, the Jules Bordet Institute and the HUDERF, support the Movember initiative and remind the importance of cancer screening for men. The frequency of prostate cancer diagnoses at a localized stage and requiring treatment has increased, especially in younger men. However, thanks to…
(read more)

Nutrition Day 2022

News 08/11/2022 The risk of malnutrition is particularly high for cancer patients The three institutions of the Brussels University Hospital (H.U.B) are taking part in Nutrition Day and raising awareness of malnutrition associated with illness in a hospital environment. The Jules Bordet Institute, reference centre in the fight against cancer, is evaluating malnutrition among cancer patients, also thanks to your input through the annual "…
(read more)

The Jules Bordet Institute Radiotherapy Department takes a step further in personalised cancer treatment

Press release (08/11/2022)  The Jules Bordet Institute Radiotherapy Department takes a step further in personalised cancer treatment The 8 November 2022 - Thursday 10 November, almost a year since it moved to the Anderlecht campus, the Jules Bordet Institute – part of the Brussels University Hospital together with the Erasmus Hospital and the Queen Fabiola Children's University Hospital – will be officially inaugurating its Radiology…
(read more)

Pink october : The Printemps study for an improved approach to fatigue

Press release (27/10/2022)  A programme to favour faster and more lasting rehabilitation for breast cancer patients 27 October 2022 – At the Jules Bordet Institute, improving knowledge of quality of life is inseparable from quality of care. This is why the first patient has joined the Printemps [Spring] study. This pilot project for a multidisciplinary approach to the fatigue experienced after breast cancer or a germ cell tumour in patients…
(read more)

Pink October : The MyPeBS study

Press release (20/10/2022)  The MyPeBS Study : « Advancing knowledge about breast cancer screening is essential» October 20, 2022 – MyPeBS (My Personal Breast Cancer Screening) is a clinical study which aims to evaluate a breast cancer screening strategy based on individual risk. The clinical study, coordinated by Unicancer (France) involves 28 partners in 6 countries (Belgium, France, Italy, United Kingdom, Israel, Spain). In Belgium it is…
(read more)

Octobre rose - Les facteurs de risque du cancer du sein 

News publiée le 18/10/2022 Octobre rose - Les facteurs de risque du cancer du sein  Il existe des facteurs de risque du cancer du sein sur lesquels on ne peut PAS agir, tels que l’âge, les mutations génétiques (gênes de type BRCA1 and BRCA2), l’histoire reproductive (avoir ses règles avant 12 ans et ménopause au-delà de 55 ans expose à davantage de variations hormonales), avoir des seins d’une densité importante, votre propre histoire…
(read more)